2/5/2026 6:25:31 PM Life Sciences Enforcement Testing the Boundaries of Competition Law By Kaylynn Moss Sean Norick Long Toyosi Taiwo Lucas Vanassche +1 more... Show less Life sciences is a high-stakes sector where antitrust enforcement is testing the boundaries of competition law. The focus differs sharply...
12/16/2025 8:19:10 PM Doing Business in High-Risk Jurisdictions – Litigation Risks in France By Dimitri Lecat Alexandra van der Meulen Béatrice Collette Gabriel Fusea +1 more... Show less France has emerged as a jurisdiction of relevance in the global trend toward holding companies accountable for human rights and...
10/2/2025 4:10:00 PM Compliance in a Global AI Market: Examining the Overlaps Between California’s SB 53 and the EU AI Act By Beth George Brock Dahl Christine Chong Vera Ibes Joseph Mason Madeline Cimino +3 more... Show less On September 29, Governor Gavin Newsom signed into law Senate Bill 53, the “Transparency in Frontier Artificial Intelligence Act”...
1/27/2025 7:48:38 PM Life sciences – what to watch in 2025 By Adam Golden Kristen Riemenschneider Madeleine Tavcar We asked more than 200 Freshfields lawyers – across geographies and practice areas: what are the 1-2 issues top of mind for you and your...
9/15/2022 5:26:11 PM Illumina/Grail: A Tale of Transatlantic Entropy By Thomas Lübbig Justin Stewart-Teitelbaum Laura Onken Lauren Vanderslice Amaryllis Müller Karen Slaney +3 more... Show less This isn’t the first time we’ve written about this US-focused transaction in the innovative markets for next generation gene sequencing...
4/14/2021 2:09:17 PM Comparing the EU’s Representative Actions Directive to US class action procedures By Linda Martin Henry Hutten This fifth blog in our series examining the EU Representative Actions Directive ("the Directive") considers how lawsuits proceeding...